Live Breaking News & Updates on Synpeptide Co Ltd

Stay updated with breaking news from Synpeptide co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Frontiers | Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

CD45, the predominant transmembrane tyrosine phosphatase in leukocytes, is required for the efficient induction of T cell receptor signaling and activation. Various studies have demonstrated that viruses can interfere with the functions of CD45 and that patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are immune-suppressed. We recently reported that the CD45-intracellular signals in peripheral blood mononuclear cells (PBMCs) of triple negative breast cancer (TNBC) patients are inhibited. We also reported that C24D, an immune modulating therapeutic peptide, binds to CD45 on immune-suppressed cells and resets the functionality of the immune system via the CD45 signaling pathway. Given the similarity between the role of CD45 in viral immune suppression, reported by others, and our findings on TNBC, we hypothesized that the C24D peptide may have a similar “immune-resetting” effect. We tested this hypothesis by comparing the CD45 intracellular signaling in PBMC ....

United States , United Kingdom , Kfar Saba , Tel Hashomer , Dawen Yu , Gen Virol , Blood Bank Mada Tel Hashomer , Meir Medical Center , World Health Organization , Institutional Review Board At Meir Medical Center , Ethics Committees Of The Meir Medical Center , National Health Commission Of Israel , Israel Ministry Of Health , Synpeptide Co Ltd , Ge Healthcare , Brief Report , Institutional Review Board , Ficoll Paque Plus , National Health Commission , Ethics Committees , Israel Ministry , Infrared Imaging System , Src Protein , Protein Phosphorylation , Med Abstract , Crossref Full Text ,